Severity
Moderate
FDA Drug recall · Reported May 14, 2025
Presence of Particulate Matter: Glass particles were found in pellet vials.
Bso LLC recalled TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This … - a moderate-severity action.
TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This … was recalled by Bso LLC in May 14, 2025. Reason: Presence of Particulate Matter: Glass particles were found in pellet vials.. Check the official notice for the remedy. Verify recall #D-0412-2025 with the FDA Drug before acting.
The recall
Bso LLC issued this moderate-severity FDA Drug recall-Presence of Particulate Matter: Glass particles were found in pellet vials..
Sourced from official FDA Drug enforcement records. Verify recall #D-0412-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0412-2025) was formally reported on May 14, 2025, with the manufacturer initiating the action on April 28, 2025. It is classified under Moderate severity (Class II), with a current status of Ongoing. Bso LLC is listed as the recalling firm, operating out of Lakewood, CO. Federal records list the affected scope as 2,762 vials.
The documented reason for this recall is: Presence of Particulate Matter: Glass particles were found in pellet vials. Distribution data in the federal record shows the product reached: Nationwide in the USA. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
2,762 vials
Related Recalls
6
5 from same agency
TESTOSTERONE PELLET 100 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0101-01
Presence of Particulate Matter: Glass particles were found in pellet vials.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | D-0412-2025 |
| Date reported | May 14, 2025 |
| Date initiated | April 28, 2025 |
| Recalling firm | Bso LLC |
| Firm location | Lakewood, CO |
| Affected scope | 2,762 vials |
| Distribution | Nationwide in the USA |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 14, 2025. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.